Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate of less than 8%, and is predicted to become the second leading cause of cancer-related death by 2030. Alongside late detection, which impacts upon surgical treatment, PDAC tumours are challenging to treat due to...
Main Authors: | Edward P. Carter, Abigail S. Coetzee, Elena Tomas Bort, Qiaoying Wang, Hemant M. Kocher, Richard P. Grose |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/4/847 |
Similar Items
-
Hepatic Hedgehog Signaling Participates in the Crosstalk between Liver and Adipose Tissue in Mice by Regulating FGF21
by: Fritzi Ott, et al.
Published: (2022-05-01) -
Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma
by: Taija Korpela, et al.
Published: (2022-01-01) -
Targeting the Cancer–Neuronal Crosstalk in the Pancreatic Cancer Microenvironment
by: Ylenia Capodanno, et al.
Published: (2023-10-01) -
Crosstalk of nervous and immune systems in pancreatic cancer
by: Fei-Fei Huang, et al.
Published: (2023-11-01) -
The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer
by: Noemí Manero-Rupérez, et al.
Published: (2020-03-01)